{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:23:27Z","timestamp":1787750607393,"version":"build-2784847793"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1001\/jamadermatol.2020.5468","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T16:34:12Z","timestamp":1611765252000},"page":"296","source":"Crossref","is-referenced-by-count":12,"title":["Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone"],"prefix":"10.1001","volume":"157","author":[{"given":"John S.","family":"Barbieri","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia"},{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Associate Editor, JAMA Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi200076r1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004-2013.","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200076r2","first-page":"632","article-title":"Frequency of treatment switching with spironolactone and oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016.","volume":"17","author":"Barbieri","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"doi200076r3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne.","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi200076r4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijwd.2019.04.024","article-title":"Hyperkalemia in women with acne exposed to oral spironolactone: a retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program.","volume":"5","author":"Thiede","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"doi200076r5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1472-6904-11-23","article-title":"The association between drospirenone and hyperkalemia: a comparative-safety study.","volume":"11","author":"Bird","year":"2011","journal-title":"BMC Clin Pharmacol"},{"issue":"1","key":"doi200076r6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200076r8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris.","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi200076r9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jaad.2018.09.055","article-title":"Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.","volume":"80","author":"Barbieri","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"9596","key":"doi200076r11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"doi200076r12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1684\/ejd.2015.2606","article-title":"Validating the diagnostic code for acne in a tertiary care dermatology centre.","volume":"25","author":"Ejaz","year":"2015","journal-title":"Eur J Dermatol"},{"key":"doi200076r13","article-title":"Validating the optimal classification approach using ICD-10 codes to identify dermatology patients with acne.","author":"Barbieri","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200076r14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jamadermatol.2014.5254","article-title":"Frequency of primary nonadherence to acne treatment.","volume":"151","author":"Anderson","year":"2015","journal-title":"JAMA Dermatol"},{"key":"doi200076r15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12895-015-0036-8","article-title":"Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.","volume":"15","author":"de Lucas","year":"2015","journal-title":"BMC Dermatol"},{"issue":"11","key":"doi200076r16","article-title":"Interventions for enhancing medication adherence.","volume":"11","author":"Nieuwlaat","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"doi200076r17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaad.2007.04.005","article-title":"Adherence to topical therapy increases around the time of office visits.","volume":"57","author":"Feldman","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200076r18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jaad.2015.01.048","article-title":"Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings.","volume":"72","author":"Straight","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200076r19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings.","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200076r20","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.jaad.2016.06.057","article-title":"Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): a retrospective cohort study.","volume":"75","author":"Barbieri","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"doi200076r21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research.","volume":"104","author":"Morris","year":"2011","journal-title":"J R Soc Med"},{"issue":"1","key":"doi200076r22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13012-017-0555-2","article-title":"The physician\u2019s experience of changing clinical practice: a struggle to unlearn.","volume":"12","author":"Gupta","year":"2017","journal-title":"Implement Sci"},{"key":"doi200076r23","article-title":"Comparative analysis of prescribing patterns of tetracycline class antibiotics and spironolactone between advanced practice providers and physicians in the treatment of acne vulgaris.","author":"Guzman","journal-title":"J Am Acad Dermatol"},{"key":"doi200076r7","unstructured":"Graber? E. Acne vulgaris: management of moderate to severe acne. UpToDate. Published online January 14, 2020. Last updated December 9, 2020. Accessed December 22, 2020. https:\/\/www.uptodate.com"},{"key":"doi200076r10","unstructured":"Optum.com. Research data assets. Published 2015. Accessed September 5, 2018. https:\/\/www.optum.com\/content\/dam\/optum\/resources\/productSheets\/5302_Data_Assets_Chart_Sheet_ISPOR.pdf"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2775574\/jamadermatology_barbieri_2021_oi_200076_1615934615.1472.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T15:01:57Z","timestamp":1615993317000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2775574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.5468","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}